Ua hoʻoholo ʻia kahi noiʻi i hana ʻia e nā mea noiʻi ma ke Kulanui ʻo Kingston, Lākana, hiki ke hoʻohana ʻia nā hiʻohiʻona maka i hana ʻia e ka naʻauao i hiki ke wānana wikiwiki a pololei inā loaʻa ke kanaka i ka maʻi puʻuwai.
Hiki i nā hopena ke wehe i ke ala no ka nānā ʻana i ka maʻi maʻi cardiovascular me ka hoʻohana ʻana i nā kamera, me ka ʻole o ka pono o nā hoʻāʻo koko a i ʻole nā ana koko.
ʻO nā maʻi kaʻapuni, e like me ka cardiovascular, coronary, heart failure and stroke, kekahi o nā kumu nui o ka maʻi a me ka make ma ka honua holoʻokoʻa, a ʻo ia ke kuleana o kēlā me kēia make ma UK. ʻOiai aia nā ʻano hana pilikia like ʻole, ʻaʻole hiki iā lākou ke ʻike pono i ka poʻe e ulu a make paha i nā maʻi kaʻa.
Ma ke ʻano he ʻāpana o ka noiʻi, ua hoʻomohala ʻo Professor of Computer Vision ʻo Kingston University ʻo Sarah Barman a me ka mea noiʻi postdoctoral Roshan Welikala i nā algorithm artificial intelligence (AI) i hiki ke ana pono i nā ʻano kiʻi o ka retina, e like me ka laulā o ka retina. o nā kīʻaha koko a me ko lākou curvature. .
Ma ka hui pū ʻana me nā hoa hana ma St George's, ke Kulanui o Lākana, ka NIHR Biomedical Research Center ma Moorfields Eye Hospital a me ka UCL Institute of Ophthalmology, a me ka MRC Epidemiology Unit ma ke Kulanui o Cambridge, e hōʻike ana e hiki i kēia mau kiʻi i hoʻokumu ʻia AI. e kuhikuhi i ka pilikia o ka maʻi maʻi cardiovascular a me ka hahau ʻana a hana ma ke ʻano he biomarker wānana ʻē aʻe i nā koʻikoʻi kūlohelohe kuʻuna no ke ola kino. Ua paʻi ʻia nā hopena ma ka puke "British Journal of Ophthalmology".
"Mahalo i kēia noiʻi ʻana, ua hōʻike mākou he ʻano maikaʻi ka nānā ʻana i ka maka o AI-powered ʻaʻole i hana mau ʻia e ka ophthalmologist ma ke alanui e like me ke ana maʻamau o ka pilikia cardiovascular," wahi a Professor Barman. "ʻO ka poʻe a pau e hele i kahi optician ma UK e kākau inoa no ka nānā ʻana i ka maka a, ʻaʻole like me nā ʻano hana maʻamau e koi ai i kahi hoʻāʻo koko e ke GP, ʻo kēia ʻano kānana e koi wale i kahi kiʻi o ka retina a me kekahi mau ʻikepili, e like me ka mea maʻi. makahiki, ua puhi a ʻaʻole paha, a me kekahi mau nīnau e pili ana i kona mōʻaukala olakino.
"ʻO kēia ʻano hana, ka mea e ʻae ai i ka nānā ʻana i ka lehulehu ma ke ʻano non-invasive e hiki ai ke alakaʻi i nā lāʻau lapaʻau mua no ka poʻe i ʻike ʻia he pilikia nui loa."
Ua hoʻomohala ka poʻe noiʻi i kahi algorithm AI-powered holoʻokoʻa, i kapa ʻia ʻo QUARTZ, e loiloi i ka hiki ke kiʻi i ka retinal vasculature me nā mea pilikia i ʻike ʻia e wānana i ke olakino vascular a me ka make. Hiki i ka algorithm ke loiloi i hoʻokahi kiʻi o ka retina ma lalo o hoʻokahi minuke.
Ua nānā ʻia nā kiʻi retinal o 88.052 UK Biobank i komo i ka makahiki mai 40 a 69 makahiki me ka algorithm, e nānā pono ana i ka laulā moku, ka ʻāpana moku a me ke degere o ka curvature e hoʻomohala i nā kumu hoʻohālike. Hoʻohana ʻia kēia mau hiʻohiʻona i nā kiʻi retinal o 7.411 mau mea komo, 48 a 92 makahiki, mai ka European Prospective Investigation into Cancer (EPIC)-Norfolk study.
Ua hoʻohālikelike ʻia ka hana QUARTZ me ka hoʻohana nui ʻana o nā pilikia pilikia Framingham. Ua hahai ʻia ke olakino o ka poʻe i komo no ka awelika o ʻehiku a ʻeiwa mau makahiki, a ua hoʻomaopopo ʻia ʻo ka helu pilikia ʻole e pili ana i ka makahiki, ke kāne, ke kūlana puhi, ka mōʻaukala olakino, a me ka retinal vasculature i hana like me ka framework Framingham .
